Citigroup raised the price target for the QuidelOrtho Corporation (NASDAQ:QDEL) stock from “a Neutral” to “a Buy”. The rating was released on December 12, 2022, according to finviz. The research report from UBS has upgraded the stock from Sell to Neutral, with a price target set at $86. The stock was initiated by Citigroup, who disclosed in a research note on September 19, 2022, to Neutral and set the price objective to $90. In their research brief published July 20, 2022, UBS analysts initiated the QuidelOrtho Corporation stock to Sell with a price target of $86.
The latest trade, Performances and Moving Averages give us the following Picture
The share price of QuidelOrtho Corporation (NASDAQ:QDEL) dipped -1.94% to close Friday’s market session at $85.03, lower as compared to yesterday’s close. The stock price fluctuated between $84.635 and $86.98 throughout the trading session with the volume trading being 671488 shares, which represented a significant variation when compared to the three months average volume of 526.61K shares. The firm’s stock price fluctuated 2.13% within the last five trades and -1.39% within the last 30 trades, which was a significant change from the beginning of this year. Despite the fact that the share price increased 2.08% in the last 6 months and 0.72% was added to its value over the previous 3 months. QDEL stock is trading at a margin of -2.51%, -2.36% and -3.60% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
As of the close of trading, QDEL deals in the Healthcare domain. The stock is trading -29.50 percent below its 52-week high and 27.14 percent above its 52-week low. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The firm’s Weighted Alpha is -21.9. A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly.
What Does QuidelOrtho Corporation’s Profitability and Valuation Ratios Tell Us About the Stock?
With regard to the profitability of the company, the operating margin is currently at 25.10 percent and the profit margin is 16.80 percent, and the company has reported a gross margin of 59.30 percent. The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. The higher the number, the more profits are generated for the company and vice versa.
The stock’s market cap achieved a total value of $5.87 billion as of the last trading session. Market capitalization is the total value of all outstanding shares of a corporation and it is used to measure a company’s market value. The price-to-earnings ratio for QuidelOrtho Corporation (NASDAQ:QDEL) is 7.99. The price-to-earnings ratio is a method of assessing corporate values by comparing them to their per-share profit. Forward P/E stands at 14.53. Forward price-to-earnings is calculated using predicted earnings for the next financial year’s P/E determination. The stock has achieved an effective Price-to-Sales Ratio of 1.80 that mirrors the cost to be found for sales by the market. The firm managed a Price-to-Book ratio of 1.14, which equates the market value of a stock with its book value.
Is Insider Trading a Real Thing?
Almost all investors and traders prefer to invest in shares controlled by the management of a corporation as a management company will be more likely to run the business itself and to never conduct things against the management’s desires and will always try to do what is best for their shareholders. Currently, 0.90 percent of QuidelOrtho Corporation shares are owned by insiders, and 97.30 percent are held by financial institutions. BUECHLER KENNETH F, the Director at QuidelOrtho Corporation (QDEL) has sold 8,081 shares of firm on Feb 17 at a price of $90.26 against the total amount of $0.73 million. In another inside trade, POLAN MARY LAKE PH D, Director of QuidelOrtho Corporation (NASDAQ:QDEL) sold 1,525 shares of the firm on Mar 18 for a total worth of $0.17 million at a price of $113.59.